| Price | 1,890.50p on 21-07-2026 at 14:54:47 |
|---|---|
| Change | 8.50p 0.45% |
| Buy | 1,890.50p |
| Sell | 1,889.50p |
| Last Trade: | Unknown 0.00 at 1,890.50p |
| Day's Volume: | 3,379,666 |
| Last Close: | 1,882.00p |
| Open: | 1,858.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,851.50p - 1,913.00p |
| 52wk Range: | 1,361.00p - 2,282.00p |
| Market Capitalisation: | £75.73b |
| VWAP: | 1,880.6253p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 0 | 1,890.50p | SI Trade |
15:54:47 - 21-Jul-26 |
| Buy* | 40 | 1,890.50p | Automatic Execution |
15:54:44 - 21-Jul-26 |
| Unknown* | 0 | 1,890.50p | SI Trade |
15:54:42 - 21-Jul-26 |
| Buy* | 546 | 1,890.50p | Automatic Execution |
15:54:41 - 21-Jul-26 |
| Sell* | 221 | 1,890.00p | Automatic Execution |
15:54:40 - 21-Jul-26 |
| Unknown* | 0 | 1,890.50p | SI Trade |
15:54:32 - 21-Jul-26 |
| Buy* | 2 | 1,890.50p | SI Trade |
15:54:29 - 21-Jul-26 |
| Buy* | 606 | 1,890.00p | Automatic Execution |
15:54:17 - 21-Jul-26 |
| Buy* | 274 | 1,890.00p | Automatic Execution |
15:54:12 - 21-Jul-26 |
| Sell* | 1,000 | 1,890.00p | Automatic Execution |
15:54:11 - 21-Jul-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 20th Jul 2026 7:00 am | RNS | Bexsero 1-dose booster EMA file acceptance |
| 17th Jul 2026 12:00 pm | RNS | Audit tender conclusion |
| 17th Jul 2026 9:30 am | RNS | Camlipixant phase III results update |
| 16th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 15th Jul 2026 1:38 pm | RNS | GSK completes acquisition of Nuvalent, Inc |
| 14th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 13th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 13th Jul 2026 7:00 am | RNS | Positive Jemperli data in dMMR/MSI-H rectal cancer |
| 10th Jul 2026 11:58 am | RNS | Hansoh positive Phase III results for Riz-Rez |
| 9th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |